Rectal Misoprostol in Women Undergoing Myomectomy for Intraoperative Blood Loss Reduction: A double-blinded randomized placebo-controlled study

Article Sidebar

Fulltext
Published: Jun 30, 2019
Keywords:
Leiomyoma Myomectomy Misoprostol Blood loss Hemoglobin

Main Article Content

Pruttaporn Maneerat
Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand
Sirikarn Tongmai
Department of Obstetrics and Gynecology, Rajavithi Hospital, Bangkok, Thailand

Abstract

Objectives: To compare amount of intraoperative blood loss between patients using preoperative rectal misoprostol versus placebo group.
Materials and Methods: A randomized double-blinded placebo-controlled trial, 46 women with uterine leiomyoma indicated for myomectomy, both abdominal and laparoscopic approach were randomly assigned and received rectal misoprostol (400 µg) or placebo at 30 minutes before operation, then estimation of blood loss was recorded as primary outcome. Changes in hemoglobin, hematocrit, rate of transfusion and adverse events were also recorded.
Results: Median and interquartile range of intraoperative blood loss in misoprostol group was 350 (613) ml and 500 (663) ml in placebo group. Mann-Whitney U test shows no statistical significance (p = 0.136). Univariate analyses showed significant factors of intraoperative blood loss were intramural type, type of operation and larger size of mass. But after multivariate analyses, the only significant factor affecting more blood loss was intramural type of leiomyoma (odds ratio 23, 95% confidence interval 1.96-271.9, p = 0.013). Changes of hemoglobin, hematocrit, transfusion rate and other complications were not significant.
Conclusion: There was no significant benefit in blood loss reduction after preoperative dose of rectal misoprostol in the study.

Article Details

How to Cite
(1)
Maneerat, P.; Tongmai, S. Rectal Misoprostol in Women Undergoing Myomectomy for Intraoperative Blood Loss Reduction: A Double-Blinded Randomized Placebo-Controlled Study. Thai J Obstet Gynaecol 2019, 27, 88-99.
Issue
VOL. 27, NO. 2: (April - June 2019)
Section
Original Article

References

1. LaMorte AI, Lalwani S, Diamond MP. Morbidity associated with abdominal myomectomy. Obstet Gynecol 1993;82:897-900.
2. Adesina KT, Owolabi BO, Raji HO, Olarinoye AO. Abdominal myomectomy: A retrospective review of determinants and outcomes of complications at the University of Ilorin Teaching Hospital, Ilorin, Nigeria. Malawi Med J 2017;29:37-42.
3. Agostini A, Ronda I, Franchi F, Bretelle F, Roger V, Cravello L, et al. Oxytocin during myomectomy: a randomized study. Eur J Obstet Gynecol Reprod Biol 2005;118:235-8.
4. Zullo F, Palomba S, Corea D, Pellicano M, Russo T, Falbo A, et al. Bupivacaine plus epinephrine for laparoscopic myomectomy: a randomized placebo-controlled trial. Obstet Gynecol 2004;104:243-9.
5. Opoku-Anane J, Vargas MV, Moawad G, Cherie M, Robinson JK. Use of Intravenous Tranexamic Acid During Myomectomy: A Randomized Double-Blind Placebo Controlled Trial. J Minim Invasive Gynecol 2015;22:S197.
6. Shaaban MM, Ahmed MR, Farhan RE, Dardeer HH. Efficacy of Tranexamic Acid on Myomectomy-Associated Blood Loss in Patients With Multiple Myomas: A Randomized Controlled Clinical Trial. Reprod Sci 2016;23:908-12.
7. Shokeir T, Shalaby H, Nabil H, Barakat R. Reducing blood loss at abdominal myomectomy with preoperative use of dinoprostone intravaginal suppository: a randomized placebo-controlled pilot study. Eur J Obstet Gynecol Reprod Biol 2013;166:61-4.
8. Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. Misoprostol administered by epithelial routes: Drug absorption and uterine response. Obstet Gynecol 2006;108(3 Pt 1):582-90.
9. Rosner B. Fundamentals of Biostatistics. Belmont, CA: Thomson-Brooks/Cole; 2006.
10. Kongnyuy EJ, Wiysonge CS. Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev 2014;8:CD005355.
11. Bose P, Regan F, Paterson-Brown S. Improving the accuracy of estimated blood loss at obstetric haemorrhage using clinical reconstructions. BJOG 2006;113:919-24.
12. Ali Algadiem E, Aleisa AA, Alsubaie HI, Buhlaiqah NR, Algadeeb JB, Alsneini HA. Blood Loss Estimation Using Gauze Visual Analogue. Trauma Mon 2016;21:e34131.
13. Celik H, Sapmaz E, Serhatlioglu S, Parmaksiz C, Altingul A. Effect of intravaginal misoprostol use on uterine artery blood flow in patients with myoma uteri. Fertil Steril 2003;80:1526-8.
14. Abdel-Hafeez M, Elnaggar A, Ali M, Ismail AM, Yacoub M. Rectal misoprostol for myomectomy: A randomised placebo-controlled study. Aust N Z J Obstet Gynaecol 2015;55:363-8.
15. Celik H, Sapmaz E. Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertil Steril 2003;79:1207-10.
16. Kalogiannidis I, Xiromeritis P, Prapas N, Prapas Y. Intravaginal misoprostol reduces intraoperative blood loss in minimally invasive myomectomy: a randomized clinical trial. Clin Exp Obstet Gynecol 2011;38:46-9.